Edition:
United States

Profile: Recordati Industria Chimica e Farmaceutica SpA (RECI.MI)

RECI.MI on Milan Stock Exchange

37.35EUR
4:12am EDT
Change (% chg)

€-0.25 (-0.66%)
Prev Close
€37.60
Open
€37.60
Day's High
€37.70
Day's Low
€37.29
Volume
46,363
Avg. Vol
658,241
52-wk High
€38.01
52-wk Low
€24.24

Recordati Industria Chimica e Farmaceutica SpA is an Italy-based group engaged in the research, development, manufacture and marketing of pharmaceuticals. It promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central nervous system, Dermatological, Gastroenterology, Genital-urinary system, Muscular-skeletal disorders and pain therapy, Obstetrics and Gynecology and over the counter (OTC) pharmaceuticals. The Company is engaged in the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases. It’s product is ZANIDIP, a latest generation calcium-channel blocker for the treatment hypertension. It operates through Italchimici SpA, Pro Farma AG and North American marketing rights to Cystadane.

Company Address

Recordati Industria Chimica e Farmaceutica SpA

Via M. Civitali, 1
MILANO     20148
P: +3902.487871
F: +3902.40073747

Company Web Links